Tate & Lyle PLC (TATE) - Total Liabilities
Based on the latest financial reports, Tate & Lyle PLC (TATE) has total liabilities worth GBX2.07 Billion GBX (≈ $251.62K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Tate & Lyle PLC to track the company's year-over-year net asset growth rate.
Tate & Lyle PLC - Total Liabilities Trend (1985–2026)
This chart illustrates how Tate & Lyle PLC's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Tate & Lyle PLC to measure how efficiently the company converts operating cash flow to free cash.
Tate & Lyle PLC Competitors by Total Liabilities
The table below lists competitors of Tate & Lyle PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Superlon Holdings Bhd
KLSE:7235
|
Malaysia | RM46.34 Million |
|
NGE Capital Ltd
AU:NGE
|
Australia | AU$1.46 Million |
|
IFS Capital (Thailand) Public Company Limited
BK:IFS
|
Thailand | ฿2.35 Billion |
|
Microbix Biosystems Inc.
TO:MBX
|
Canada | CA$10.22 Million |
|
Bumi Teknokultura Unggul Tbk
JK:BTEK
|
Indonesia | Rp3.26 Trillion |
|
Live Ventures Inc
NASDAQ:LIVE
|
USA | $293.93 Million |
|
Aciselsan Acipayam Seluloz Sanayi Ve Ticaret AS
IS:ACSEL
|
Turkey | TL352.95 Million |
|
Primary Health Properties
LSE:PHP
|
UK | GBX3.48 Billion |
Liability Composition Analysis (1985–2026)
This chart breaks down Tate & Lyle PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tate & Lyle PLC stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tate & Lyle PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tate & Lyle PLC (1985–2026)
The table below shows the annual total liabilities of Tate & Lyle PLC from 1985 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | GBX2.07 Billion ≈ $251.62K |
-3.50% |
| 2025-03-31 | GBX2.14 Billion ≈ $260.74K |
+105.47% |
| 2024-03-31 | GBX1.04 Billion ≈ $126.90K |
-20.80% |
| 2023-03-31 | GBX1.32 Billion ≈ $160.24K |
-19.25% |
| 2022-03-31 | GBX1.63 Billion ≈ $198.45K |
+7.80% |
| 2021-03-31 | GBX1.51 Billion ≈ $184.09K |
+4.20% |
| 2020-03-31 | GBX1.45 Billion ≈ $176.67K |
+11.35% |
| 2019-03-31 | GBX1.30 Billion ≈ $158.66K |
+8.31% |
| 2018-03-31 | GBX1.20 Billion ≈ $146.49K |
-16.33% |
| 2017-03-31 | GBX1.44 Billion ≈ $175.08K |
-5.64% |
| 2016-03-31 | GBX1.52 Billion ≈ $185.55K |
+2.56% |
| 2015-03-31 | GBX1.49 Billion ≈ $180.92K |
+4.87% |
| 2014-03-31 | GBX1.42 Billion ≈ $172.53K |
-19.02% |
| 2013-03-31 | GBX1.75 Billion ≈ $213.05K |
-5.25% |
| 2012-03-31 | GBX1.85 Billion ≈ $224.85K |
-11.07% |
| 2011-03-31 | GBX2.08 Billion ≈ $252.83K |
-14.63% |
| 2010-03-31 | GBX2.43 Billion ≈ $296.15K |
-18.49% |
| 2009-03-31 | GBX2.99 Billion ≈ $363.31K |
+25.25% |
| 2008-03-31 | GBX2.38 Billion ≈ $290.06K |
+15.34% |
| 2007-03-31 | GBX2.07 Billion ≈ $251.49K |
+2.63% |
| 2006-03-31 | GBX2.01 Billion ≈ $245.05K |
+19.74% |
| 2005-03-31 | GBX1.68 Billion ≈ $204.65K |
+40.17% |
| 2004-03-31 | GBX1.20 Billion ≈ $146.01K |
-14.35% |
| 2003-03-31 | GBX1.40 Billion ≈ $170.46K |
-13.52% |
| 2002-03-31 | GBX1.62 Billion ≈ $197.11K |
-17.30% |
| 2001-03-31 | GBX1.96 Billion ≈ $238.35K |
+5.04% |
| 2000-03-31 | GBX1.86 Billion ≈ $226.92K |
-7.95% |
| 1998-09-30 | GBX2.03 Billion ≈ $246.51K |
-0.29% |
| 1997-09-30 | GBX2.03 Billion ≈ $247.22K |
-6.83% |
| 1996-09-30 | GBX2.18 Billion ≈ $265.35K |
+14.30% |
| 1995-09-30 | GBX1.91 Billion ≈ $232.16K |
+13.62% |
| 1994-09-30 | GBX1.68 Billion ≈ $204.32K |
+3.21% |
| 1993-09-30 | GBX1.63 Billion ≈ $197.97K |
+6.63% |
| 1992-09-30 | GBX1.53 Billion ≈ $185.67K |
+4.64% |
| 1991-09-30 | GBX1.46 Billion ≈ $177.43K |
+18.27% |
| 1990-09-30 | GBX1.23 Billion ≈ $150.02K |
-16.11% |
| 1989-09-30 | GBX1.47 Billion ≈ $178.82K |
+17.24% |
| 1988-09-30 | GBX1.25 Billion ≈ $152.53K |
+160.14% |
| 1987-09-30 | GBX481.90 Million ≈ $58.63K |
+3.92% |
| 1986-09-30 | GBX463.70 Million ≈ $56.42K |
+32.98% |
| 1985-09-30 | GBX348.70 Million ≈ $42.43K |
-- |
About Tate & Lyle PLC
Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company's products are used in bev… Read more